GLPG1837

· Galapagos NV

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for GLPG1837, covering 2015-09-09 to 2016-12-07. Get the full timeline:

Most recent: Clinical Trial Update: Study of GLPG1837 in Subjects With Cystic Fibrosis (G551D Mutation) [Phase 2]